Pylo Health Launches Two Cellular-Connected Remote Patient Monitoring Devices

AmericaCura & TerapiaProdotti e tecnologie

Pylo Health has announced the launch of two next-generation patient devices: the Pylo 900-LTE blood pressure monitor and the Pylo 200-LTE weight scale, both of which are clinically validated and connect to multiple cellular networks to better ensure reliable data transmission throughout the United States.

The 900-LTE and 200-LTE are available for use with the Prevounce remote care management platform and integrate with independent health applications and management systems via the Pylo cloud API.

The 900-LTE is Pylo’s latest blood pressure monitor for patients enrolled in remote patient monitoring (RPM) programs for hypertension and related chronic conditions. With roaming 4G/5G connectivity and 2G fallback, the blood pressure monitor requires no configuration and connects patients in even the most difficult to reach rural areas. A new, remotely configurable “triple measurement mode” automatically collects a sequence of three readings to meet the latest American Heart Association blood pressure measurement guidelines. Patients benefit from a comfortable cloth cuff with a broad arm size range and an intuitive user interface.

The new 200-LTE weight scale also comes with Pylo’s industry-leading roaming cellular connectivity and requires no patient setup. Weight measurements accurate to 0.1 lbs are securely delivered to care teams monitoring patients enrolled in RPM programs for heart failure, medical weight loss, bariatric surgery, and more. A modern, low-profile design allows for patient ease of use, while streamlined packaging lowers shipping costs for healthcare organizations. The 200-LTE is a more economical and compact alternative to Pylo’s 300-LTE Plus scale for patients weighing less than 450 lbs.

“Ongoing remote blood pressure and weight monitoring are low-barrier and highly effective additions to primary care, cardiology, gastroenterology, bariatric, and other remote care programs,” says Daniel Tashnek, founder and CEO of Pylo and Prevounce. “Cumbersome, unreliable hardware can get in the way of programs realizing their full clinical and financial potential. We’re excited to introduce new Pylo devices that are not only highly advanced, accurate, and dependable, but also comfortable and simple for patients to use.”